Showing results (211-220 of 248) with videos related to
Sort By:
Pageof 25
The Journal of Urology|May 25, 2021
Pathological Downstaging and Survival Outcomes Associated with Neoadjuvant Chemotherapy for Variant Histology Muscle Invasive Bladder CancerNicholas H Chakiryan, Da David Jiang, Kyle A Gillis, et al.Urologic Oncology|July 30, 2023
First analysis of the safety and efficacy of UGN-101 in the treatment of ureteral tumorsJoseph M Jacob, Solomon L Woldu, Jennifer Linehan, et al.CA: a Cancer Journal for Clinicians|April 21, 2020
Innovations in research and clinical care using patient-generated health dataHeather S L Jim, Aasha I Hoogland, Naomi C Brownstein, et al.European Urology Oncology|February 16, 2023
Cost Effectiveness of Treatment Sequences in Advanced Renal Cell CarcinomaNeil T Mason, Vidhu B Joshi, Jacob J Adashek, et al.The Journal of Urology|October 25, 2017
Development of a 90-Minute Integrated Noninvasive Urinary Assay for Bladder Cancer DetectionEllen Wallace, Russell Higuchi, Malini Satya, et al.Oncology|November 17, 2011
Combination therapy for renal cell cancer: what are possible options?Napoleon Santos, Justin B Wenger, Pamela Havre, et al.Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches|October 6, 2022
Hospital Surgical Volume Is Poorly Correlated With Delivery of Multimodal Treatment for Localized Pancreatic Cancer: A National Retrospective Cohort StudyBenjamin D Powers, James McDonald, Rahul Mhaskar, et al.Journal of Surgical Education|September 20, 2017
Creation of a Novel Digital Rectal Examination Evaluation Instrument to Teach and Assess Prostate Examination ProficiencyMatthew B Clements, Karen M Schmidt, Steven E Canfield, et al.Lancet (London, England)|March 13, 2016
Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trialNaomi B Haas, Judith Manola, Robert G Uzzo, et al.Cancer|January 31, 2014
Sharpening the focus on causes and timing of readmission after radical cystectomy for bladder cancerMichael Hu, Bruce L Jacobs, Jeffrey S Montgomery, et al.Pageof 25